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Vitamin E and Fatty Acid Intervention Does Not 
Attenuate the Progression of Atherosclerosis in 
Watanabe Heritable Hyperlipidemic Rabbits
Henne A. Kleinveld, Heidi L.M. Hak-Lemmers, Magda P.C. Hectors, Nanneke J. de Fouw,
Pierre N.M. Demacker, Anton F.H. Stalenhoef
Abstract We investigated the effect of different interventions 
on aortic atherosclerosis in Watanabe rabbits. Four groups of 
rabbits were fed either an oleic acid-enriched diet (80% of total 
fat intake) with or without vitamin E supplementation (250 IU/kg) 
or a diet enriched in linoleic acid with or without vitamin E 
supplementation for 6 months. At the start of the study, plasma 
cholesterol concentration was 21.4±3.6 mmol/L (n=32). The 
diets did not influence the mean plasma lipids and lipoprotein 
concentrations except for HDL cholesterol, which was increased 
more on the oleic acid— enriched diets than on the linoleic 
acid-enriched diets. Vitamin E levels in plasma and LDL were 
increased on the oleic acid diet and reduced on the linoleic acid 
diet. On the latter diet, supplementation of vitamin E was 
quantitatively less effective in raising plasma or LDL vitamin E 
levels. The susceptibility of LDL to oxidation was determined in 
vitro. Both oleic acid-enriched diets increased the lag time by
140% from baseline. The linoleic acid diet supplemented with 
vitamin E increased lag time by 59%. Linoleic acid alone, how­
ever, decreased the lag time by 30%. Similar but inverse effects 
were seen on LDL oxidation rate. Thus, intervention protected 
LDL to oxidation in the following order: oleic acid plus vitamin 
E>oleic acid>linoleic acid plus vitamin E>linoleic acid. Despite 
the differences in LDL oxidizability induced by the four experi­
mental diets, assessment of aortic atherosclerosis at the end of the 
6-month dietary study period revealed no differences among the 
four study groups. These results suggest that a decrease in the 
oxidative susceptibility in vitro alone is not sufficient to attenuate 
atherogenesis when cholesterol levels remain markedly elevated. 
(Arterioscler Thromb Vase Biol. 1995;15:290-297.)
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xidation of LDL is believed to be an important 
step in the process of atherogenesis.1*2 Several 
lines of evidence support this concept,3-8 but 
the strongest evidence conies from studies in which 
treatment with the synthetic antioxidant probucol 
slowed the progression of atherosclerotic lesion forma­
tion in Watanabe heritable hyperlipidemic (WHHL) 
rabbits, an animal model for homozygous familial 
hypercholesterolemia.1*-10
In vitro, several cell types have been shown to oxidize 
LDL.'1' 14 The cell-mediated oxidation can be mimicked 
in a cell-free system with copper as a prooxidant.15 LDL 
oxidation can be monitored continuously by measuring 
diene production as a measure of lipid peroxidation. 
This method allows a sensitive assessment of various 
indexes that together describe the oxidizability of LDL. 
Typically, oxidation of LDL can be divided into three 
consecutive phases: (1) a lag phase during which there is 
almost no diene production, (2) a propagation phase 
characterized by a rapid increase in diene production, 
and (3) a decomposition phase during which diene 
production reaches its maximum and then the dienes 
start to decompose. Copper-induced in vitro oxidation of 
LDL has been used widely to evaluate the effectiveness
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of antioxidant therapy and dietary intervention on LDL 
oxidizability. It has been shown that in vitro and in vivo 
supplementation of LDL with vitamin E, the major 
lipophylic antioxidant, increases its resistance against 
oxidation.16*18 This suggests that the oxidation resistance 
of LDL is determined primarily by its vitamin E (anti­
oxidant) content; in other words, the lag phase should be 
predictable from the vitamin E (antioxidant) status of a 
particular LDL sample. However, in our assay with 
highly reproducible oxidizability, we found no such 
correlation.15 This indicates that other factors contribute 
to the oxidizability of LDL.
Traditionally, dietary advice has included a reduction 
in total fat and replacement of saturated fat by unsatur-
ated fat.19 Diets in which saturated acids are
substituted for polyunsaturated fatty acids lower plasma 
cholesterol levels.20"22 A recent meta-analysis of 27 trials 
clearly showed that substitution of saturated fat for 
unsaturated fat created a more favorable lipoprotein risk 
profile for coronary heart disease.23 Diets rich in mono­
unsaturated fatty acids have also been shown to lower 
plasma LDL cholesterol levels.20'22-26 Comparatively lit­
tle is known about the effect of dietary enrichment with 
unsaturated fatty acids on atherosclerosis. A recent 
study in African green monkeys showed that dietary 
polyunsaturated fatty acids reduced atherosclerosis de­
velopment compared with saturated fat.27 Similar effects 
in African green monkeys have been observed for di­
etary fish oil and monounsaturated fat.28-29
One of the first steps in the oxidative modification of 
LDL is the peroxidation of polyunsaturated fatty acids.u> 
Theoretically, LDL rich in polyunsaturated fatty acids
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T able  1. Fatty Acid Composition and Vitamin E Content of 
Experimental Diets
Component
Study Diet
Oleic Linoleic Oleic+E Linoleic+E
6.7 7.0 6.7 7.0
4.3 2.6 4.3 2.6
74.6 13.1 74.6 13.1
12.6 76,0 12.6 76,0
0.1 0.3 0.1 0.3
50.9 46.5 50.9 46,5
Fatty acid 
Palmitic acid (16:0)
Stearic acid (18:0)
Oleic acid (18:1)
Linoleic acid (18:2)
Linolenic acid (18:3)
Vitamin E, mg/kg 
d-«-Tocopherol
DL-a-Tocopherol acetate . . .  . . .  250 250
Four diets were studied: an oleic acid-enriched diet (Oleic), a linoleic acid-enriched diet 
(Linoleic), and two similar diets, each supplemented with 250 mg vitamin E per 1 kg (Oleic+E 
and Linoleic-l-E, respectively). Vitamin E in the diets is natural D-a-tocopherol (1 mg=1.49 IU 
vitamin E) derived from the vegetable oils used. The Oleic+E and Linoleic+E diets were 
supplemented with synthetic DL-a-tocopherol acetate (1 mg=1 IU vitamin E).
‘ Percentage of total fat.
should be more easily oxidized and therefore may be 
more atherogenic. Plasma LDL of rabbits and humans 
fed a diet rich in oleic acids is more resistant to oxidation 
compared with linoleic acid.25-30'31 A recent dietary study 
by Bonanome et al32 showed that the in vitro peroxida­
tion rate of plasma LDL was inversely correlated with 
the ratio of oleic acid to linoleic acid in the LDL particle. 
We recently found that the peroxidation rate of plasma 
LDL also is determined in the basal state by this ratio.33 
Moreover, the resistance of LDL against oxidation (lag 
time) and the extent of oxidation (total diene produc­
tion) were shown to be highly correlated positively and 
negatively, respectively, with the ratio of oleic acid to 
linoleic acid.33 If LDL oxidation proves to be an impor­
tant step in atherogenesis, then diets rich in monounsat­
urated fatty acids supplemented with lipophilic antioxi­
dants would be the strategy of choice in providing
sufficient protection against oxidative modification. In 
the present study, we evaluated the effect of such a 
combination on the susceptibility of LDL to oxidation 
and the development of aortic atherosclerosis in the 
WHHL rabbit.
Methods
Animals and Study Design
Thirty-two homozygous WHHL rabbits were raised by cross­
ing and backcrossing with New Zealand White (NZW) rabbits. 
The animals were housed individually in wire-bottom stainless- 
steel cages under controlled light. Until the start of the study, 
the rabbits were fed a standard rabbit chow (LK04 diet, Hope 
Farms) containing 3% (wt/wt) fat, with 40% linoleic acid (18:2) 
and 20% oleic acid (18:1). The standard chow contained 
0.007%' (wt/wt) DL-cif-tocopherol acetate (1 m g=l IU). The 
rabbits were divided into four groups of eight animals with 
matched ages, body weights, and serum cholesterol and serum 
triglyceride concentrations. Their mean age at the start of the 
study was 5.0±1.7 months (range, 3.5 to 7 months).
The groups were fed semisynthetic diets containing 10% 
(wt/wt) fat. The diets were prepared fresh each month and
at — 40°C until use. The diet components were calcium 
caseinate (186 g/kg), mineral mixture (39.5 g/kg), fat mixture 
(100 g/kg), starch (453.5 g/kg), liber (166 g/kg), grass meal (50 
g/kg), and vitamin mixture (5 g/kg). The diets contained 30% of 
calories as fat, 50% as carbohydrates, and 20% as protein. The 
diets differed only in their fatty acid composition and vitamin E 
content (Table 1). Two groups received a linoleate (safflower
oil)-enriched diet containing approximately 75% linoleic acid; 
the two other groups received an oleate (Trisun 80)-enriched 
diet that contained approximately 75% oleic acid. One li- 
noleate-enriched diet and one oleate-enriched diet were sup­
plemented with extra vitamin E (DL-a-tocopherol acetate); the 
final vitamin E concentration in the supplemented diets was 
250 mg/kg (0.025%, wt/wt). The nonsupplemented diets con­
tained 0.005% (wt/wt) vitamin E. Each rabbit was given 100 g 
of their respective diets daily for 6 months. Water was provided 
ad libitum. Dietary consumption and weight gain did not differ 
among the animals of the four groups during the study period.
Blood Sampling
Fasting blood samples were obtained from the marginal ear 
vein at the start of the study; after 1,2, and 4 months; and at the 
end of the study period (6 months). Blood samples were 
collected into tubes containing 0.1 mL 15% (wt/vol) EDTA 
(Merck). Plasma was stored at —80°C until assayed. Before the 
samples were frozen, saccharose (6 mg/mL) was added to the 
plasma to stabilize the lipoproteins.
LDL Isolation and Oxidation
LDLs were isolated by a short-run ultracentrifugation meth­
od15 followed by in vitro copper-induced LDL oxidation.15 In 
brief, after isolation the LDL was dialyzed for 24 hours in the 
dark at 4°C against phosphate-buffered saline (pH 7.4) contain­
ing 10 jumol/L EDTA. The buffer was made oxygen-free by 
vacuum degassing followed by purging with nitrogen. The 
LDL-containing sample was filtered through a 0.45-/nm filter 
and diluted with dialysis buffer to a final concentration of 0.05 
mg LDL protein per milliliter and 1 /xmol EDTA/L. The 
oxidation was initiated by the addition of a freshly prepared, 
15-jamol/L CuCl2 solution. The kinetics of the oxidation of 
LDL was determined by monitoring the change of the 234-nm 
diene absorption on a UV spectrophotometer (Lambda 5, 
Perkin-Elmer) equipped with a six-position automatic sample 
changer at 30°C. The change of absorbance at 234 nm versus 
time was divided into three consecutive phases, ie, lag, propa­
gation, and decomposition phases. Lag time, maximal rate of 
oxidation, and total amount of conjugated dienes formed per 1 
mg LDL protein were calculated as described.15 Addition of 3 
or 10 /x-g vitamin E dissolved in 10 ju,L isopropanol per milliliter 
of LDL did not quench the absorbance (at 234 nm) of control 
LDL.
In Vivo Lipid Peroxidation
The content of thiobarbituric reactive substances (TBARS), 
mainly malondialdehyde (MDA), in plasma was measured by 
recording the fluorescence spectrum of the thiobarbituric acid-
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T able 2. Plasma Lipids and Lipoproteins at Baseline and After 6 Months in Four 
Groups of Eight WHHL Rabbits on Experimental Diets
Study Diet
Baseline Oleic Linoleic Oleic+E Linoleic+E
Total cholesterol 21.4+3.6 23.7+4.0* 21.9+3.8 25.4+4.6 24.2±4.5
Triglycerides 2.72±1.51 1.50+0.57* 1.36±0.37* 1.40±0.40* 2.03+1.04
VLDL+IDL
cholesterol 6.4±3.4 11.6+2.8* 9.4±3.2 12.4+4.4* 10.6+3.5*
LDL cholesterol 14.8±3.5 11.8±2.4t 12.3+2.8 12.7 i2 .7 t 13.3+3.3
HDL cholesterol 0.20+0.05 0.36±0.17* 0.25±0.10* 0.37±0.09* 0.25+0.08
WHHL indicates Watanabe heritable hyperlipidemic rabbits. Composition of the diets is as shown in Table 1. 
Results are expressed in mmol/I.
*P<.05, *P<.001 vs baseline.
MDA complex between 500 and 600 nm on a Shimadzu 
RFF-5000 recording spectrofluorometer (Shimadzu), with a 
constant interval of 14 nm maintained between excitation and 
emission wavelengths.34 The fluorescence intensity was mea­
sured at 553 nm after subtraction of the baseline value (owing
to the Rayleigh diffusion). This synchronous fluorescence 
method was found to be free from interfering compounds.34
Extent of Aortic Atherosclerosis
At the end of the study period, the rabbits were anesthetized 
intramuscularly with 0.1 mL/kg Hypnorm (Janssen Pharmaceu- 
tica). The entire aorta from the aortic valve to the iliac 
bifurcation was removed, cleaned of excess adventitial tissue, 
and rinsed with saline. The aortas were opened by a longitu­
dinal incision over the total length and fixed between two glass 
plates for at least 24 hours in 10% buffered formaldehyde 
solution. After fixation, the aortas were stained with Sudan IV 
(Sigma Chemical Co) to identify lipid-containing atheroscle­
rotic plaques. The area covered with atherosclerotic lesions was 
quantified with a computer-assisted planimetry system (Kon- 
tro-Vidasplus system) coupled to a video camera (Sony). The 
extent of atherosclerotic lesions was quantified for the total 
aorta and for the three segments divided by the first intercostal 
artery and the celiac artery: the aortic arch, the descending 
thoracic aorta, and the abdominal aorta.
Other Methods
Total cholesterol, free (unesterified) cholesterol, phospho­
lipids, and triglycerides in LDL samples were determined by 
commercially available enzymatic methods (numbers 237574, 
310328, and 691844, Boehringer-Mannheim, and number 6639, 
Miles Laboratories, respectively). LDL protein was determined 
by the method of Lowry et al.35
Cholesterol and triglyceride concentrations in plasma were 
determined with enzymatic methods. Plasma HDL cholesterol 
was determined by the polyethylene glycol 6000 method.36 The 
plasma VLDL+IDL fraction (*/< 1.019 kg/L) was isolated by 
sequential u ltracentrifugation37; LDL was isolated at 
1.019<d<  1.063 kg/L. Fatty acids in LDL were determined by
gas chromatography.33 The vitamin E concentrations in LDL 
and plasma were determined by high-performance liquid chro­
matography as described previously.38
Statistical Analysis
Results are expressed as mean±SD. Unless otherwise indi­
cated, differences among group means were analyzed by one­
way ANOVA. Differences among group means that developed 
during the 6-month study period were analyzed by multivariate 
analysis of variance. For comparisons among groups, Student’s 
(unpaired) two-sample t test was used. For paired observations, 
data were analyzed by Student’s t test. A two-tailed probability 
value of less than .05 was considered significant. Statistical 
analyses were performed with procedures available in the 
spss/pc + statistical package (SPSS Inc).
Results
Plasma Lipids and Lipoproteins
Table 2 shows the effects of the four diets on plasma 
lipid and lipoprotein levels. Total plasma cholesterol 
concentration in the rabbits was strongly elevated 
throughout the study; the basal concentration was 
21.4±3.6 mmol/L. Except for the rabbits on the oleic 
acid-enriched diet (Oleic), total cholesterol concentra­
tions were not changed after the 6-month study period. 
In contrast, plasma triglycerides declined in almost all 
dietary groups. Also, LDL cholesterol tended to be 
lower during the study period; in the rabbits on the oleic 
acid-enriched diets (Oleic and Oleic+E), this decrease 
was significant. VLDL+IDL cholesterol and HDL cho­
lesterol concentrations increased most markedly on the 
oleic acid-enriched diets.
Only the effects of the four diets on plasma HDL 
cholesterol were significantly different; ie, the oleic acid- 
enriched diets resulted in higher HDL cholesterol concen­
trations than did the linoleic acid-enriched diets (Oleic
Table 3. Vitamin E («-Tocopherol) in Plasma and LDL in Four Groups of WHHL Rabbits on 
Experimental Diets for 6 Months
Diet Baseline 1 Month 2 Months 4 Months 6 Months
Plasma, mg/L Oleic 20.2 ±5.7 25.9+6.5* 34.8+4.8* 43.0±8.2* 34.5+5.2*
Linoleic 20.2±7.8 14.2 + 11.5* 13.4+5.5* 17.4±5.8 13.0+2.7*
Oleic + E 17.8+2.9 68.1+18.7* 84.6 + 16.1* 86.4±13.4* 51.8±7.8*
Linoleic+E 19.0+7.2 48.1+9.0* 66.3 + 12.5* 81.0+9.4* 62.0 + 17.1*
LDL, mg/g LDL protein Oleic 3.92±1.02 4.58 + 0.77 5.87±0.85f 6.12+1.51* 6.66±1.13*
Linoleic 3.90+0.83 2.24±0.36* 2.01 ±0.57* 2.54±0.54* 2.11 ±0.76*
Oleic+E 3.94±0.65 12.90+2.58* 13.74 + 4.13* 14.10±4.13* 10.47+2.52*
Linoleic+E 3.81 + 1.79 9.17+1.42* 11,20±1.41* 12.30+1.56* 10.56 + 1.80*
Composition of the diets is as shown in Table 1. n=8 Watanabe heritable hyperlipidemic (WHHL) rabbits for each dietary group. 
*P<.05, tP<-01, *P < .001 vs baseline.
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Table 4. Fatty Acid Composition of LDL at Baseline and After 6 Months in Four Groups of WHHL 
Rabbits Fed an Experimental Diet
Experimental Diet
Fatty Acid Baseline (n=32) Oleic Linoleic Oleic+E Linoleic+E
Palmitic acid (16:0) 22.0±1.8 17.7±1.1$ 18.9±1.4f 18.4±0.6$ 18.1 ±1.1$
Stearic acid (18:0) 8.7 + 0.5 8.0±0.7* 8.5±0.5 8.0 ±0.3* 8.6 * 0.6
Oleic acid (18:1) 22.8±2.3 46.7+2.1$ 17.8+1.8$ 43.7 ±2.0$ 16.7' 0.7*
Linoleic acid (18:2) 38.7+2.2 23.6±1.9$ 49.4+2.9$ 25.4 ±1. 5$ 52.4 ±1.5$
Linoienic acid (18:3) 3.0±0.5 0.7±0.2$ 1.0±0.2$ 1,1 +0.3$ 0.7+0.3$
Arachidonic acid (20:4) 4.8 + 1.0 3.4±0.7$ 4.5+0.8 3.4+1.1$ 3.6 ± 1.11
M m *
Experimental diets are as shown in Table 1. n=8 Watanabe heritable hyperllpldemlc (WHHL) rabbits for each group. Results are 
expressed as weight percentage of total fatty acids.
*P<.05, $P<.01, $P<.001 vs baseline.
F =.01; Oleic+E versus i c + E
F=.0()1; MANOVA).
Vitamin E in Plasma and LDL
Table 3 summarizes plasma and LDL vitamin E levels. 
The Oleic diet resulted in a significant increase in both 
plasma and LDL vitamin E levels. After 4 months, 
plasma vitamin E reached a peak at 43.0±8.2 mg/L, an 
increase of 113% from baseline levels. Vitamin E in 
LDL was maximal at 6 months with 6.66± 1.13 mg/g 
LDL protein, an increase of 70% from baseline. In 
contrast, the Linoleic diet resulted in a decrease of 
plasma vitamin E and the vitamin E content of LDL. 
After 6 months on this diet, plasma vitamin E levels had 
decreased 36% to 13.0±2.7 mg/L. In the same period, 
LDL vitamin E content was reduced 46% to 2.11±0.76 
mg/g LDL protein. The effects of the Oleic diet on 
plasma vitamin E and on vitamin E in LDL were 
significantly different from the effects of the Linoleic diet 
(both Pc.OOi). Both vitamin E-supplemented diets re­
sulted in comparable increases of vitamin E concentra­
tions in plasma and LDL.
Fatty Acid Content and Chemical 
Composition of LDL
Table 4 shows the fatty acid composition of plasma 
LDL. No difference in fatty acid composition of LDL 
was found between the Oleic group and the Oleic+E 
group;
Linoleic group and the Linoleic+E group. The oleic acid 
and linoleic acid content of LDL in the Oleic groups 
differed significantly from those of the Linoleic group. 
Oleic acid was approximately 45% of total fatty acids in 
LDL from rabbits on the Oleic diets; in rabbits on 
Linoleic diets, this was <20%;. The linoleic acid content 
in the rabbits fed Oleic diets was approximately 25%; in
was a
rabbits fed the Linoleic 
was approximately 50%.
all diet 
acid (16:0) and 
baseline.
ind linoleic
(18:3) 
group on the I
of LDL was c
diets showed an
re-
€
tional decrease of the stearic acid (18:0) content of their
LDL.
The change from normal rabbit chow to 
diets resulted in a general alteration in the chemical 
composition of LDL (Table 5); this change was basically 
the same for all diet groups. Both free cholesterol and 
cholesterol ester content of LDL increased on 
synthetic diets; in contrast, the relative content of tri­
glycerides decreased. Protein content was unchanged in
two groups, s in ; group on
and slightly increased in the
Linoleic+E diet.
LDL Oxidation
Fig 1 shows typical examples of LDL oxidation curves, 
s figure clearly shows the effect of a monounsat­
urated fatty acid-enriched diet and a polyunsatun
fatty acid diet on the oxidation profile of LDL. Fi
shows the effects of the four different diets on 1
At baseline, mean lag time was 105.0± 14.9 minutes
(n=32). After only 1 month on
differential were apparent. LDL of the rabbits
that received the Linoleic diet appeared significantly less 
resistant against oxidation; in general, lag time was
approximately 30% compared with baseline. 
The other three diet groups showed an increase in lag 
time; for the Linoleic+E group, the increase was 59% 
after 6 months. Although the Oleic+E diet was more
Table 5. Chemical Composition of LDL at Baseline and After 6 Months in Four Groups of WHHL 
Rabbits Fed Different Experimental Diets
Experimental Diet
Baseline (n=32) Oleic Linoleic Oleic+E Linoleic+E
Free cholesterol 9.1 ±0.5 10.3 ±0.7* 9.7 ±0.3$ 10.0 < 0.51 0.8 ‘ 0.7$
Cholesterol esters 42.1+4.3 46.9+2.3* 46.8 ±1.8* 46.8+2.6’ 44.6 ±3.4
Triglycerides 7.5±3.5 3.5 ±1.9$ 3.2 +1.1$ 3.8 •1.8* 5.1 '2.9*
Phospholipids 18.6±0.9 18.4+0.6 18.0 ±0.5 18.3 + 7.8 17.4 + 0.7*
Protein 22.7±1.5 20.9+1.4* 22.3+1.1 21.2 ±1.2 23.7 ± 1.4*
NNM*
Experimental diets are as shown in Table 1. n 
expressed as weight percentage of total LDL. 
Pc.05, tP<.01, $P<.001 vs baseline.
8 Watanabe heritable hyperlipidemic (WHHL) rabbits for each group. Results are
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Fig 1. Graph shows typical examples of LDL oxidation curves 
as determined by continuous measurement of the diene absor­
bance during copper-induced in vitro oxidation. LDL was iso­
lated from Watanabe heritable hyperlipidemic rabbits at the 
beginning of the study (•), after 1 month on a linoleic acid- 
enriched diet (o), and after 1 month on an oleic acid-enriched 
diet (a ). Lag times of the curves are indicated. Effects of the 
dietary Interventions on oxidation rate (slope of the curve) and on 
the extent of the oxidation (maximal diene absorbance) are 
clearly shown.
effective than the Oleic diet in the first 4 months of the 
study period (lag time of LDL at 4 months on the 
O leic+E diet was 316.3±73.7 minutes), both diets re­
sulted in a similar 140% increase in lag time after 6 
months. All differences in lag time between the diet 
groups were significant (P c .01) except for the effect of 
Oleic versus O leic+E on lag time after 6 months.
Similar but inverse effects were seen on maximal rate 
of diene production (Fig 3). At baseline, the mean 
oxidation rate was 11.2±1.8 nmol • min 1 • m g“1 LDL 
protein (n=32). The Linoleic diet increased the rate 
maximally by 46% (after 4 months). In contrast, the
Linoleic+E, and O leic+E  diets resulted in a
decrease in the oxidation rate of 10%, 55%, and 68%, 
respectively.
Fig 4 shows the effect of the synthetic diets on the 
third parameter of LDL oxidizablity, the total diene 
production. At baseline, the mean total diene produc-
20
nmol/min/mg LDL-protein
15
10 -
5 -
0
0 1 2
months
4 6
Fig 3. Bar graph shows the effect of antioxidative intervention 
on maximal oxidation rate of LDL. Four groups (n=8) of Wa­
tanabe heritable hyperlipidemic rabbits were fed a diet enriched 
in oleic acid, linoleic acid, oleic acid plus vitamin E, or linoleic 
acid plus vitamin E. At the indicated time points, LDL was 
isolated and the susceptibility to copper-induced in vitro oxida­
tion was determined. Inset legend as in Fig 2.
tion was 590.8±52.7 nmol/mg LDL protein (n=32). The 
Oleic diet resulted in a 40% decrease in diene produc­
tion; the Linoleic diet gave a 10% to 20% increase in 
diene production. In both cases, vitamin E supplemen­
tation had no additional effect on total diene production.
Lipid Peroxidation
As an indication of in vivo lipid peroxidation, TBARS 
were determined in plasma at baseline and after 6 
months on the experimental diets. The mean initial 
plasma TBARS concentration was 0.73±0.14 nmol/mL. 
At the end of the study period, TBARS in the Oleic 
group were significantly (P=.004) reduced to 0.56±0.10 
nmol/mL compared with baseline. TBARS in the Lino­
leic, Oleic + E, and L in oleic+ E  diet groups were
0.86±0.'13, 0.66±0.13, and 0.62±0.06 nmol/mL, respec­
tively. ANOVA revealed that the differences among the 
groups after 6 months were significant (Pc.001). Statis­
tical testing indicated that this difference was caused by 
the TBARS increase in the Linoleic group.
400
min
300
2 0 0
100
0
[//.iV.-vy 1
linoleic 
linoleic + E 
oleic
3 oleic + E
0 1 2
months
4 6
Fig 2. Bar graph shows the effect of antioxidative intervention on 
the lag time of LDL oxidation. Four groups (n=8) of Watanabe 
heritable hyperlipidemic rabbits were fed a diet enriched in oleic 
acid, linoleic acid, oleic acid plus vitamin E, or linoleic acid plus 
vitamin E. At the Indicated time points, LDL was isolated and the 
susceptibility to copper-induced in vitro oxidation was determined.
1000 nmol/mg LDL-protein
800
600
400
2 0 0
0
0 1 2
m onths
4 6
Fig 4. Bar graph shows the effect of antioxidative intervention 
on maximal diene production during LDL oxidation. Four groups 
(n=8) of Watanabe heritable hyperlipidemic rabbits were fed a 
diet enriched in oleic acid, linoleic acid, oleic acid plus vitamin E, 
or linoleic acid plus vitamin E. At the indicated time points, LDL 
was isolated and the susceptibility to copper-induced in vitro 
oxidation was determined. Inset legend as in Fig 2.
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Table 6. Percentage of Aortic Surface Covered With Atherosclerotic
Lesions in Four Groups of WHHL Rabbits Fed Different Experimental 
Diets for 6 Months
Oleic
Aortic arch 
Thoracic aorta 
Abdominal aorta 
Total aorta
91 ±3  
77±10  
22±14  
65±9
Experimental Diet
Linoleic Oleic-f E
89±3  
67±25  
2 5 ± 1 1 
59±18
90±3
65±20
24±17
59±14
Linoleic+E
89±7  
62 ±32  
22±16  
56±23
Experimental diets are as shown in Table 1. n=8 Watanabe heritable hyperlipidemic
(WHHL) rabbits (age 5.0±1.7 months) for each group. Lesions were evaluated after Sudan IV 
staining of the aorta.
Aortic Atherosclerosis
At the end of the study period, all rabbits were killed, 
their aortas were removed, and the extent of aortic 
atherosclerosis was determined. No significant differ­
ences were observed in the extent of atherosclerotic 
lesion formation among the four groups (Table 6). This 
accounts for the total aorta and the three defined 
subregions of the aorta.
Discussion
Strongest evidence for the oxidation hypothesis of 
atherosclerosis came from the probucol studies in 
WHHL rabbits.9’10 Feeding 1% (wt/wt) probucol (0.4 
g/kg body weight) to WHHL rabbits for 6 months 
retarded the progression of atherosclerosis when started 
at the age of 2 months; this was independent of the 
cholesterol-lowering effect of probucol.9’10 This anti­
atherogenic effect of 1% probucol feeding was also 
demonstrated in cholesterol-fed rabbits and mon­
keys.39’40 In one study in cholesterol-fed rabbits, a pro­
tective effect of probucol could not be demonstrated.41 
Mao et al42 reported the effects of a probucol analogue 
without a cholesterol-lowering effect in attenuating ath­
erosclerosis in WHHL rabbits. In accordance with the 
present study, antioxidant therapy reduced the suscepti­
bility of LDL to oxidation but failed to affect atheroscle­
rosis development significantly. Fruebis et al43 recently 
studied another probucol analogue with an antioxidant 
potency that in vitro was equal to that of probucol. The 
bioavailability of the probucol analogue was much 
greater than that of probucol. When this analogue was 
given at 0.05% (wt/wt) to WHHL rabbits, similar plasma 
levels were achieved as with 1% (wt/wt) probucol. 
Despite these similar plasma levels, lesion development 
was not affected by treatment with the analogue, 
whereas probucol slowed lesion progression by almost 
50%. These studies with probucol analogues strongly 
suggest that the antiatherogenic effect of probucol is 
probably less related to its antioxidant properties than 
was initially believed and that other biological effects 
contribute to its antiatherogenic potential.
The present study differs in several aspects from 
earlier reports that showed an antiatherogenic effect of 
antioxidant therapy. In most animal experiments, the 
antioxidant dosages applied, usually in the range of 0.5% 
to 1.0% (wt/wt), are unrealistic for evaluation in hu­
mans.9-10’44 It is obvious that the efficacy of lower doses 
should preferably be evaluated in combination with 
other measures, such as an optimal composition of the 
fatty acids in the diet. Therefore, we evaluated in the 
present study in WHHL rabbits the efficacy of 0.025%
(wt/wt) of vitamin E in the food, which corresponds to a  
daily dose of 10 mg/kg body weight. The rationale fo r  
choosing vitamin E was that in WHHL rabbits, th is  
natural product in a dose of 0.025% was at least as  
effective as probucol in decreasing the susceptibility o f  
LDL to oxidation in vitro.45 As an additional preventive 
measure, we evaluated the exchange of linoleic acid with  
oleic acid. For maximal response and discriminating 
power, we enhanced the amount of fat in the diet from  
3% to 10%. On this diet, total plasma cholesterol did n o t  
show a systematic difference compared with the basal 
diet, whereas plasma triglycerides decreased approxi­
mately 40%. This decrease probably induced a shift o f  
the apolipoprotein B-100-containing lipoproteins t o ­
ward a lower density range accompanied by increased 
concentrations in the VLDL+IDL fraction and a d e ­
crease in LDL cholesterol (Table 2). In the present 
study, we confirmed the HDL cholesterol sparing effect 
of oleic acid versus linoleic acid as observed previously 
in humans.22
It appeared that three of the four diets—the linoleic  
acid-enriched diet with additional vitamin E and th e  
oleic acid-enriched diets with and without additional 
vitamin E —resulted in an increased resistance to in vitro  
oxidation; the linoleic acid-enriched diet without v ita­
min E supplementation showed a decreased resistance 
against oxidation. The improved resistance of L D L  
against oxidation was clear not only from an increased 
lag time but also from a decreased maximal oxidation 
rate. These are both known to be beneficially influenced 
by an increased vitamin E content45 and an increased 
ratio of oleic acid to linoleic acid content in LDL .33 
Reduced oxidizability is achieved not only by delaying 
the onset of oxidation but also by reducing the amount 
of available substrate for oxidation. The latter is r e ­
flected in the decreased amounts of dienes produced in 
the LDL of the oleic acid-supplemented animals. H ow ­
ever, despite the fourfold difference in lag time an d  
oxidation rate and the twofold difference in total d iene  
production, we failed to observe any difference in th e  
aortic lesion surface after 6 months of intervention w ith  
these diets. We found similar results recently when w e  
compared antioxidant treatment in three groups o f  
WHHL rabbits.45 Two groups were treated with low  
doses of either vitamin E or probucol; the third group  
acted as control. Despite significant reductions in th e  
susceptibility of LDL to oxidation, antioxidant treatment 
did not influence atherosclerosis development compared 
with the control group. From these results, it is clear th at  
many more factors determine the outcome of athero­
sclerosis intervention studies by antioxidants, especially
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when physiological dosages are administered. One very 
important factor is the age at which the prevention is 
started. For a realistic evaluation, we deliberately initi­
ated intervention in WHHL rabbits of approximately 5 
months of age. Another important factor is the magni­
tude of the plasma cholesterol concentration in the 
WHHL rabbits: the concentrations in our rabbits were 
almost twofold higher than reported in the other two 
studies.9-10 At these concentrations, plasma TBARS 
were elevated compared with the levels in healthy 
human volunteers and NZW  rabbits (P.N.M.D., unpub­
lished observations), indicating significantly increased 
lipid-peroxidized lipoproteins in the circulation of 
WHHL rabbits, in agreement with previous results.46 At 
these high serum cholesterol concentrations, a successful 
intervention, especially when applied in adult rabbits at 
a physiological antioxidant concentration, probably 
needs a duration of more than 6 months, if not several 
years. It could also be that atherosclerosis is attenuated 
only when antioxidants are given in relatively high 
amounts and that in the present study, the degree of 
antioxidative protection was insufficient to influence 
atherogenesis. Fruebis et al43 suggested that there is a 
threshold level of protection that would represent the 
minimum necessary to exert an antiatherogenic effect. In 
this context, they mentioned a lag time of more than 400 
minutes. Interestingly, such an increase was not achieved 
in our study. Of course, additional research is needed to 
test this hypothesis.
Given the positive results concerning retardation of 
atherosclerosis regression in WHHL rabbits after partial 
ileal bypass surgery47 or after treatment with 3-hydroxy- 
3-methylglutaryl coenzyme A  inhibitors,48 it is obvious 
that normalization of plasma lipids, especially of choles­
terol, remains the first choice in a program preventing 
atherosclerosis. This is especially true because polyun­
saturated fatty acids, despite their increased oxidizability 
in vitro and in vivo, are effective in preventing athero­
sclerosis27 and coronary heart disease.40 From this study, 
it is obvious that the antioxidation hypothesis needs 
adaptation concerning the quantitative importance of 
the contributing factors.
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